To validate the reproducibility of these findings and determine the association with specific pathologic features of HCC and with survival, we further performed immunohistochemistry assay of PARP1, GS and NDRG1 in another independent cohort including 180 paired HCCs and PLs. This evidence concerns the gene PARP1 and hepatocellular carcinoma.